Wyeth Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Physician assistant fired for reporting to VAERS tells her story.

Despite some concerns to the contrary, federal preemption properly applied does not conflict with federalism. In fact, the two are quite compatible and can work together to ensure that regulatory decisions are not left up to state courts, which are susceptible to the machinations of America’s tort bar. Presently pending before the Supreme Court, Bruesewitz v. Wyeth, Inc., addresses the question of whether federal law preempts lawsuits asserting both strict liability and negligent design defect claims related to vaccines. The Third Circuit upheld the vaccine preemption and the Supreme Court m...

Takeaway: Over ten years, the Maryland False Health Claims Act has returned $160M to the State. This Digest summarizes each of the 173 matters reported under the Act from 2011 through...

No. Arkansas has not adopted alternative or market share liability, but has retained the traditional requirement of proximate cause in all tort cases. See Woodward v. Blythe, 249 Ark....

Monday, December 21, 2020 In a year where the use of “unprecedented” became routine, COVID-19 dominated just about every aspect of life, and its impact on drug and device law was no less encompassing. As we bid adieu and good riddance to 2020, we pause, once again, to reflect on the most significant legal developments for our drug and device clients this year. Below is a brief recap and assessment of our top five developments in drug and device law for the year. 1. Snap Removal Continues Its Momentum In April, the Fifth Circuit Court of Appeals joined the Second and Third Circui...